weight · loss

Pramlintide

FDA: FDA-approved

Pramlintide is an analog of the hormone amylin, co-secreted with insulin by pancreatic beta cells. It slows gastric emptying, suppresses post-meal glucagon, and promotes satiety, improving blood glucose control in type 1 and type 2 diabetes. Analog of amylin, a hormone co-secreted with insulin by pancreatic beta cells. Slows gastric emptying to reduce post-meal glucose spikes. Suppresses post-meal glucagon secretion. Promotes satiety and reduces food intake. Complements insulin action through a different mechanism. - Blood sugar control improvement - Satiety support and appetite reduction - Post-meal glucose spike reduction - Type 1 and type 2 diabetes management - Weight management

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —

Half-life —

CAS number —

Route —

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE

CMP
CBC
Fasting Glucose
HbA1c
Fasting Insulin

DURING CYCLE

Fasting Glucose
HbA1c

POST-CYCLE

CMP
Fasting Glucose
HbA1c

Safety & Regulatory Status

FDA STATUS FDA-approved

Regulatory status for Pramlintide may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.